Physician profile
Christopher Mark Kohan
NPI 1740532092
$3,310.99
in general payments reported to CMS, 2019-2025
9 companies · $592 in 2025
The $592 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $940 · 2023: $106 · 2024: $1,507 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Travel and Lodging: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.81 |
| Travel and Lodging | $911.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,505.80 | 2024-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Intuitive Surgical, INC. | $849.91 | 2022 | |
| Getinge USA Sales, LLC | $421.23 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Abiomed | $289.50 | 2025 | |
| Medtronic, INC. | $95.25 | 2023-2024 | Signia |
| Haemonetics Corporation | $63.07 | 2025 | Teg6s Hemostasis System |
| Becton, Dickinson and Company | $37.86 | 2024 | Hemosphere |
| Solventum Corporation | $33.71 | 2025 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice, Prevena |
| Terumo Cardiovascular Systems Corporation | $14.66 | 2024 | Cdi Blood Parameter Monitoring System 550, Herc Flex Universal Stabilizer Arm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.